American Asset Management Inc. Abb Vie Inc. Transaction History

American Asset Management Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$64.5 - $97.79 $634,809 - $962,449	-9,842 Closed	0 $0
Q4 2019 Jan 30, 2020	SELL	$72.13 - $90.25 $27,697 - $34,656	-384 Reduced 3.76%	9,842 $871,000
Q3 2019 Oct 28, 2019	BUY	$62.98 - $75.72 $315,529 - $379,357	5,010 Added 96.05%	10,226 $774,000
Q2 2019 Jul 31, 2019	BUY	$65.7 - $83.98 $62,415 - $79,781	950 Added 22.27%	5,216 $379,000
Q1 2019 Apr 15, 2019	BUY	$77.14 - $90.79 $3,857 - $4,539	50 Added 1.19%	4,266 $344,000
Q4 2018 Feb 05, 2019	SELL	$77.85 - $96.01 $7,784 - $9,601	-100 Reduced 2.32%	4,216 $389,000
Q1 2018 May 03, 2018	SELL	$92.01 - $123.21 $69,007 - $92,407	-750 Reduced 14.8%	4,316 $409,000
Q4 2017 Jan 17, 2018	SELL	$89.56 - $98.21 $17,912 - $19,642	-200 Reduced 3.8%	5,066 $490,000
Q3 2017 Nov 13, 2017	SELL	$69.85 - $89.22 $243,427 - $310,931	-3,485 Reduced 39.82%	5,266 $468,000
Q2 2017 Aug 07, 2017	BUY	N/A	8,751	8,751 $635,000

3,849

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $324B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of American Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on American Asset Management Inc. with notifications on news.